Enhabit, Inc. (NYSE:EHAB) Receives $11.50 Consensus Price Target from Brokerages

Enhabit, Inc. (NYSE:EHAB) has received an average rating of “Moderate Buy” from the eight research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and six have given a buy rating to the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $11.6250.

A number of equities analysts recently issued reports on the company. Cowen upgraded Enhabit to a “buy” rating in a report on Tuesday. UBS Group upgraded Enhabit from a “neutral” rating to a “buy” rating and increased their price target for the company from $8.50 to $12.00 in a research report on Thursday, January 8th. Deutsche Bank Aktiengesellschaft upgraded Enhabit to a “buy” rating in a report on Tuesday. Truist Financial set a $10.50 target price on shares of Enhabit and gave the stock a “hold” rating in a report on Wednesday, January 7th. Finally, Wolfe Research set a $12.00 target price on shares of Enhabit in a research report on Thursday, January 8th.

Enhabit Stock Up 0.7%

Shares of EHAB stock opened at $10.88 on Tuesday. Enhabit has a 1 year low of $6.47 and a 1 year high of $11.27. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.58 and a current ratio of 1.58. The business’s fifty day moving average is $9.22 and its 200-day moving average is $8.26. The stock has a market cap of $550.38 million, a PE ratio of -43.50 and a beta of 1.66.

Enhabit (NYSE:EHAB) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.12 by $0.05. Enhabit had a positive return on equity of 3.91% and a negative net margin of 1.14%.The business had revenue of $263.60 million during the quarter, compared to analyst estimates of $267.08 million. Enhabit has set its FY 2025 guidance at 0.500-0.560 EPS. Equities analysts expect that Enhabit will post 0.22 earnings per share for the current fiscal year.

Institutional Trading of Enhabit

Several large investors have recently added to or reduced their stakes in EHAB. AQR Capital Management LLC lifted its holdings in shares of Enhabit by 115.6% in the first quarter. AQR Capital Management LLC now owns 215,341 shares of the company’s stock valued at $1,867,000 after purchasing an additional 115,456 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Enhabit by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 29,813 shares of the company’s stock valued at $262,000 after buying an additional 1,248 shares during the period. Jones Financial Companies Lllp lifted its stake in Enhabit by 110,987.5% in the 1st quarter. Jones Financial Companies Lllp now owns 8,887 shares of the company’s stock worth $78,000 after acquiring an additional 8,879 shares in the last quarter. Empowered Funds LLC boosted its position in Enhabit by 8.4% during the 1st quarter. Empowered Funds LLC now owns 190,514 shares of the company’s stock worth $1,675,000 after acquiring an additional 14,690 shares during the period. Finally, Acadian Asset Management LLC purchased a new position in Enhabit during the 1st quarter valued at about $114,000.

Enhabit Company Profile

Enhabit, Inc (NYSE: EHAB) is a national provider of home-based healthcare services, offering a continuum of care designed to support patients in the comfort of their own homes. The company’s core mission is to deliver personalized clinical and non-clinical services that help individuals recover from illness or injury, manage chronic conditions, and, when necessary, receive compassionate end-of-life care. Enhabit’s business model centers on combining skilled clinical care with patient-centric service coordination to optimize outcomes and enhance the overall care experience.

The company’s service portfolio includes skilled nursing, physical, occupational and speech therapies, personal care assistance, palliative care and hospice services.